Advertisement

Topics

Companies Related to "A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax)." [Most Relevant Company Matches] RSS

03:04 EDT 14th August 2018 | BioPortfolio

Here are the most relevant search results for "A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax)." found in our extensive corporate database of over 50,000 company records.

Showing "Study Assess Effect Ketoconazole Metabolism Navitoclax" Companies 1–25 of 971

Relevant

Protalex, Inc.

Protalex, Inc. is a clinical stage biopharmaceutical company that is developing a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including but not limited to, rheumatoid arthritis. Protalex’s lead product PRTX-100, which is formulated with a highly-purified form of staphylococcal protein A, has completed a Phase 1b...


Imposter Research

IMPOSTER is the name of a medical research study of patients with muscle symptoms while taking cholesterol lowering therapies called statins. Several important findings from this study have been published and have raised questions about the safety of statin therapy for patients with muscle complaints. This website was developed to address those questions and to share what is known about statin mu...

International Society for the Study of Xenobiotics

Man's use of xenobiotics dates from antiquity but interest in foreign compound metabolism dates from only the mid-19th century when the knowledge and techniques of organic chemistry were first applied to its study. For nearly a century thereafter biotransformation was generally equated with "detoxication" or the elimination of a compound's biological activity.This view changed in the late 1930s wi...


Eminent effect

The eminent effect is a consultancy aiming to stand out from the crowd in tackling many of today’s people and business challenges. The company offers organisation specific training, development, sales/marketing and interim management solutions not off the shelf packages.Primarily working within the NHS, Pharmaceutical and Biotechnology sectors, the eminent effect personnel can offer experience g...

Agios Pharmaceuticals, Inc.

Agios is the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases. Agios has multiple first-in-class programs in cancer metabolism and inborn errors of metabolism advancing toward the clinic, in addition to an active research and discovery pipeline across ...

MedAvante, Inc.

MedAvante is the premier global provider of centralized expert psychiatric rating and monitoring services to the pharmaceutical, biotechnology and medical device industries. Our flagship service, Remote Centralized Ratings are real-time assessments, either by telephone or videoconference, of subjects in global drug trials. Centralizing the assessors and blinding them to study protocols, results in...

Agios Pharmaceuticals , Inc.

Agios Pharmaceuticals is focused on discovering and developing novel investigational medicines to treat cancer and rare genetic disorders of metabolism through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both therapeutic areas, Agios has multiple first-in-class investigational m...

Genelex

Genelex is a pioneer in comprehensive medication management, pharmacogenetic testing and analysis. Its patented YouScript Personalized Prescribing Software is the only commercially-available medication management system to assess the cumulative effect of a patient’s genetics and entire drug regimen. YouScript is an Allscripts Developer Program Approve...

Aranesp

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.Important Product Safety InformationAranesp® is contraindicated in patien...

Orangetheory Fitness

Orangetheory Fitness emphasizes the science of excess post-exercise oxygen consumption. The concept of heart-rate-monitored training is designed to keep heart rates in a target zone that stimulates metabolism and increases energy. Led by skilled instructors, participants use a variety of equipment including treadmills, rowing machines, SBT Suspension ...

Agios Pharmaceuticals

Agios Pharmaceuticals is the first biopharmaceutical company dedicated to the discovery and development of novel therapeutics in the emerging field of cancer metabolism. To support and drive these efforts, Agios is building a robust platform integrating cancer biology, metabolomics, biochemistry and informatics to enable target and biomarker identification...

Essentys AB

Essentys AB is an innovative biotech company developing therapeutics for the treatment and prevention of diseases in the elderly.The Company is currently focused on the development of its lead product ES 1 in osteoporosis, in which proof of concept has been obtained in clinical phase II studies. ES 1 constitutes a completely new approach to the treatment and prevention of osteoporosis. The data su...

Pharmakin GmbH

Founded in 1987, Pharmakin has since then successfully provided competent bioanalysis and pharmacokinetic evaluation of new chemical entities, marketed drugs and their metabolites. Analysis is performed in GLP-certified laboratories by our highly qualified expert staff. State-of-the-art bioanalytical techniques are applied to all analytical procedures. Pharmakin’s services also include pharmacok...

Xceleron Inc

Pioneer of Acceleratory Mass Spectrometry For Drug Development Xceleron was founded in 1997 in York, UK and has since expanded its operations with a US facility in Maryland, providing bioanalytical accelerator mass spectrometry (AMS) services for accelerated early drug development. The company pioneered human microdose and microtracer techniques using ultra-sensitive AMS to investigate the p...

American Asian Bio-Pharma Services, Inc

AA Bio-Pharma is a Clinical Research Organization (CRO) with US headquarters. It specializes in serving pharmaceutical, biotechnology, and medical device companies worldwide for pre-clinical and clinical studies in Asia, China. In the past years, AA Bio-Pharma with its partners in China has provided drug development services for sponsors around the world.Our services include:Pre-clinical Researc...

Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

Dr. Kim-Chi Vu

One of only a handful of female plastic surgeons in Portland, Dr. Kim-Chi Vu attended the University of Portland as an undergraduate and graduated from medical school at the Oregon Health Sciences University, where she also completed her surgical residency. Dr. Vu certified by the American Board of Plastic Surgery, specializes in not only cosmetic and reconstructions, but also in hand trauma surge...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

Orasi Medical

Orasi Medical develops products to measure the effect of neurological treatments and track the progression of neurological disorders. Pharmaceutical companies use Orasi Index(TM), the company's flagship product, to reduce costs and improve clinical development of neurological treatments. Orasi's high-resolution measurement of brain function provides a robust, non-invasive and reproducible measure ...

Symbiotic Research Services

SR is a contract research organization (CRO) which is licensed to conduct research with radio labeled C-14 materials. SR has been inspected by the US-EPA and the NJ-DEP Division of Radioactive Materials. SR is a full GLP compliant laboratory that has expanded its services over the years to cover a broad range of agrochemical R&D services such as product ch...

i3 Statprobe

Because we're strong in every area, you can outsource an entire study to i3 Statprobe, or outsource, for example, only the statistical programming for a single study. Or you can outsource only the statistical programming for every study. Use us any way you want to, we encourage it. For example, we'll provide a dedicated team of specialists (say, data coordinators or statistical programmers) to wor...

Probably Relevant

Numab

Founded in 2011, Numab discovers and develops innovative antibody-based therapeutics. Applying proprietary rabbit-based antibody discovery and engineering technology, Numab generates highly potent and stable antibody Fv fragments, which serve as building blocks to create mono- or bi-specific antibody fragment-based therapeutics with tailored pharmacokineti...

Celsis IVT

Celsis IVT, a subsidiary of Celsis International Ltd, is the premier world provider of specialized in vitro products for the study of metabolism, drug-drug interactions and toxicity in drug discovery and development. Since 1990, pharmaceutical and biotechnology companies have relied on Baltimore-based Celsis IVT for quality in vitro products for lead optim...

BioClin Therapeutics, Inc.

BioClin Therapeutics, Inc. is a privately-held clinical stage drug development company developing biologics to address medical conditions in areas of high unmet need. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). B-701 is currently being evaluated in t...

Celsis International Ltd.

Celsis IVT is the premier world provider of specialized in vitro products for the study of metabolism, drug-drug interactions and toxicity in drug discovery and development. Since 1990, pharmaceutical and biotechnology companies have relied on Baltimore-based Celsis IVT for quality in vitro products for lead optimization. Celsis IVT products deliver faster time to results, enabling more productive...


More From BioPortfolio on "A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-263 (Navitoclax)."

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks